Unknown

Dataset Information

0

Liver-enriched activator protein 1 as an isoform of CCAAT/enhancer-binding protein beta suppresses stem cell features of hepatocellular carcinoma.

ABSTRACT: Purpose:Liver cancer stem cells (CSCs) are known to be associated with the development, survival, proliferation, metastasis, and recurrence of liver tumors. The aim of this study was to investigate the association of liver-enriched activator protein 1 (LAP1) with hepatocellular carcinoma (HCC) and liver CSCs (LCSCs) and explore the impact of LAP1 on LCSCs. Materials and methods:Differences in LAP1 expression in liver cancer tissues versus matched para-tumoral liver tissues and LCSCs versus non-CSCs were analyzed by Western blotting, real-time polymerase chain reaction, immunohistochemistry, and flow cytometry. The effect of LAP1 on liver cancer cells was evaluated by the expression of CSC markers, oncosphere formation, proliferation, migration, and invasion in vitro. Cell cycle distribution and the number of apoptotic cells were analyzed to assess cell cycle and cell apoptosis. Furthermore, a mouse subcutaneous tumor implant model was established to explore the role of LAP1 in the development of HCC in vivo. Finally, the expression of CSC markers in paraffin-embedded sections was evaluated by immunofluorescence. Results:LAP1 was weakly expressed in HCC tumors and cell lines and even weaker in LCSCs. LAP1 inhibited the expression of stem cell-associated genes and reduced the abilities of oncosphere formation, proliferation, migration, and invasion in vitro. Cell cycle assay revealed that LAP1 induced G1/G0 arrest. Furthermore, LAP1 decreased subcutaneous tumor-formation ability and the expression of CSC markers and Ki67 in vivo. Conclusion:LAP1 suppressed the stem cell features of HCC, indicating that it possessed an antitumor effect in liver cancer, both in vitro and in vivo; therefore, LAP1 may prove to be a potential target in liver CSC-targeted therapy.

SUBMITTER: Yang LH 

PROVIDER: S-EPMC5927340 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Liver-enriched activator protein 1 as an isoform of CCAAT/enhancer-binding protein beta suppresses stem cell features of hepatocellular carcinoma.

Yang Li-Hua LH   Wang Ye Y   Qiao Shi S   Wang Min-Jun MJ   Chen Fei F   Zi Xiao-Yuan XY   Li Jian-Xiu JX   Zhang Hai-Bin HB   Yu Bing B   Hu Yi-Ping YP  

Cancer management and research 20180426

<h4>Purpose</h4>Liver cancer stem cells (CSCs) are known to be associated with the development, survival, proliferation, metastasis, and recurrence of liver tumors. The aim of this study was to investigate the association of liver-enriched activator protein 1 (LAP1) with hepatocellular carcinoma (HCC) and liver CSCs (LCSCs) and explore the impact of LAP1 on LCSCs.<h4>Materials and methods</h4>Differences in LAP1 expression in liver cancer tissues versus matched para-tumoral liver tissues and LCS  ...[more]

Similar Datasets

Unknown Hepatocyte-specific CCAAT/enhancer binding protein α restricts liver fibrosis progression.
| S-EPMC10977981 | biostudies-literature
Unknown CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.
| S-EPMC3577786 | biostudies-literature
Unknown The CCAAT/enhancer-binding protein beta-2 isoform (CEBP?-2) upregulates galectin-7 expression in human breast cancer cells.
| S-EPMC4008383 | biostudies-literature
Unknown Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer-binding protein beta (C/EBPbeta) isoform 2.
| S-EPMC2781404 | biostudies-literature
Unknown CCAAT/enhancer binding protein ? predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma.
| S-EPMC4365685 | biostudies-literature
Unknown Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.
| S-EPMC4599259 | biostudies-literature
Unknown CCAAT/Enhancer Binding Protein ? inhibits myogenic differentiation via ID3.
| S-EPMC6226455 | biostudies-literature
Unknown CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model.
| S-EPMC3855209 | biostudies-other
Unknown Identification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1.
| S-EPMC3234963 | biostudies-literature
Unknown Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress.
| S-EPMC2504880 | biostudies-other